Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants

B Chatterjee, SS Thakur - Expert Review of Vaccines, 2022 - Taylor & Francis
ABSTRACT Introduction Appearances of SARS-CoV-2 variants have created havoc and
additional challenges for the ongoing vaccination drive against pandemic COVID-19 …

Vaccines against SARS-CoV-2 variants and future pandemics

T Park, H Hwang, S Moon, SG Kang, S Song… - Expert review of …, 2022 - Taylor & Francis
Introduction Vaccination continues to be the most effective method for controlling COVID-19
infectious diseases. Nonetheless, SARS-CoV-2 variants continue to evolve and emerge …

SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies

W Gong, S Parkkila, X Wu… - International reviews of …, 2023 - Taylor & Francis
The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has become a global threat. Despite strict control measures …

SARS-CoV-2 variants, current vaccines and therapeutic implications for COVID-19

HY Liang, Y Wu, V Yau, HX Yin, S Lowe, R Bentley… - Vaccines, 2022 - mdpi.com
Over the past two years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has caused hundreds of millions of infections, resulting in an unprecedented pandemic of …

SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic

Y Shao, Y Wu, Y Feng, W Xu, F Xiong, X Zhang - Frontiers of medicine, 2022 - Springer
The record speed at which Chinese scientists identified severe acute respiratory syndrome
Coronavirus 2 (SARS-CoV-2) and shared its genomic sequence with the world, has greatly …

SARS-CoV-2 targets and COVID-19 vaccines

AW Currier, MC Jeshurin, VB Sampson - COVID, 2021 - mdpi.com
Coronavirus disease-2019 (COVID-19) vaccines are being used across the globe to reduce
the risk of developing COVID-19, stop the transmission of severe acute respiratory syndrome …

Understanding the mechanisms for COVID-19 vaccine's protection against infection and severe disease

H Yang, Y Xie, C Li - Expert Review of Vaccines, 2023 - Taylor & Francis
Introduction Multiple COVID-19 vaccines have been approved and employed in the fight
against the pandemic. However, these vaccines have limited long-term effectiveness against …

Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?

G Joshi, P Borah, S Thakur, P Sharma… - Human Vaccines & …, 2021 - Taylor & Francis
ABSTRACT As of September 2021, 117 COVID-19 vaccines are in clinical development,
and 194 are in preclinical development as per the World Health Organization (WHO) …

Comprehensive narrative review of real-world COVID-19 vaccines: Viewpoints and opportunities

S Liu, M Kang, N Zhao, Y Zhuang, S Li, T Song - Medical Review, 2022 - degruyter.com
Currently, people all over the world have been affected by coronavirus disease 2019
(COVID-19). Fighting against COVID-19 is the top priority for all the countries and nations …

COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

WY Chi, YD Li, HC Huang, TEH Chan, SY Chow… - Journal of biomedical …, 2022 - Springer
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …